GlaxoSmithKline sales and marketing update

Incruse is a once-daily long-acting muscarinic antagonist (LAMA) delivered via the Ellipta inhaler. Incruse comes in a seven-dose supply of 62.5 µg/actuation with a WAC of $63.01 and a 30-dose supply ...